Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bausch Health Companies Inc
(NY:
BHC
)
6.205
-0.155 (-2.44%)
Streaming Delayed Price
Updated: 3:24 PM EDT, May 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Bausch Health Companies Inc
< Previous
1
2
3
4
5
Next >
ROSEN, A GLOBAL AND LEADING LAW FIRM , Encourages Bausch Health Companies Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BHC
August 08, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
BAUSCH HEALTH COMPANIES INC. (NYSE: BHC) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch Health Companies Inc.
August 08, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bausch Health Companies Inc. (BHC)
August 07, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
Ortho Dermatologics Announces 2023 Aspire Higher Scholarship Recipients
July 27, 2023
Via
ACCESSWIRE
Salix Announces 2023 Gastrointestinal Health Scholars Program Winners
July 11, 2023
Via
ACCESSWIRE
Salix to Present Data from XIFAXAN(R) (Rifaximin) Clinical Research at EASL's International Liver Congress(TM) 2023
June 19, 2023
Via
ACCESSWIRE
Bausch Health Announces 2023 Annual Meeting of Shareholder Results
May 17, 2023
Via
ACCESSWIRE
Attention Bausch Health Companies Inc. (BHC) Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against Bausch Health Companies Inc.
August 05, 2023
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
BHC INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Bausch Health Companies Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
August 04, 2023
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Bausch Health Announces Second-Quarter 2023 Results, Other Key Updates From the Quarter, and Raises Full-Year 2023 Revenue Outlook
August 03, 2023
Via
ACCESSWIRE
Bausch Health Companies Inc. (BHC) Class Action Alert: Robbins LLP Reminds Investors of Pending Lead Plaintiff Deadline in Class Action Against Bausch Health Companies Inc.
August 02, 2023
From
Robbins LLP
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Bausch Health Companies Inc. (BHC) Investors
August 02, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
BHC INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Bausch Health Companies Inc. Investors with Substantial Losses Have Opportunity to Lead the Bausch Health Class Action Lawsuit
August 02, 2023
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
BHC DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch Health Companies Inc.
August 02, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Bausch Health Companies Inc. (BHC) Investors
August 01, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Bausch Health Companies Inc. (BHC) Investors
August 01, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Bausch Health Companies Inc. (BHC) on Behalf of Investors
July 31, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Bausch Health Companies Inc. (BHC) on Behalf of Investors
July 28, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Bausch Health Companies Inc. (BHC) on Behalf of Investors
July 28, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
BAUSCH HEALTH COMPANIES INC. (NYSE: BHC) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch Health Companies Inc.
July 28, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Bausch Health Companies Inc. (BHC)
July 27, 2023
From
Robbins LLP
Via
Business Wire
BHC EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages Bausch Health Companies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BHC
July 27, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3
July 13, 2023
Via
ACCESSWIRE
OraPharma to Participate in the First-Ever Research and Technology Pavilion Sponsored by Pacific Dental Services(R) at the American Dental Hygienists' Association (ADHA(R)) Annual Conference
July 07, 2023
Via
ACCESSWIRE
Bausch Health Enters Into $600 Million Financing Facility With KKR
July 07, 2023
Via
ACCESSWIRE
Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)
June 30, 2023
Via
ACCESSWIRE
Bausch Health Responds to Norwich's ANDA Tentative Approval and Lawsuit Against United States Food and Drug Administration
June 06, 2023
Via
ACCESSWIRE
Zoetis Declares New Dividend, Hinting At Undervaluation
May 18, 2023
Zoetis shareholders woke up to news of JAB's acquisition of Pumpkin, a per insurance platform where Zoetis owns a minority stake. 2023 outlooks suggest a rally
Via
MarketBeat
New Clinical Study Suggests the Use of OraPharma’s ARESTIN(R) (minocycline HCl) Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis
May 18, 2023
Via
ACCESSWIRE
U.S. District Court Upholds Final Judgment for XIFAXAN(R) 550 mg That Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
May 17, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.